Effect of baseline body mass index (BMI; < 30 kg/m2, ≥30-< 35 kg/m2, and ≥35 kg/m2) on glycaemic response and weight change in patients with type 2 diabetes (T2DM) with baseline HbA1c ≥7.5% after treatment with the once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA), dulaglutide, and active comparators in five clinical studies (AWARD 1 – 5)

Subjects

Subjects :

medicine.medical_specialty
business.industry
Endocrinology, Diabetes and Metabolism
Weight change
Once weekly
Type 2 diabetes
medicine.disease
Endocrinology
Internal medicine
medicine
Dulaglutide
In patient
business
Body mass index
After treatment
Glucagon-like peptide 1 receptor
medicine.drug

Details

ISSN :

18619010 and 18619002

Volume :

10

Database :

OpenAIRE

Journal :

Diabetologie und Stoffwechsel

Accession number :

edsair.doi...........3a404d30f8d8dd4b2f7914ff72bad29d

Full Text :

https://doi.org/10.1055/s-0035-1549752